David Weingarden, MD
Physical Medicine & Rehabilitation · Clinton Township, MINPI 1851394654
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 26 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 15 manufacturers reported payments, led by UCB, Inc. at 25.2% of the total. Reporting peaked in 2023 at $315 and has fallen 83.4% since, to $52 in 2025.
Across 26 payments — averaging $22.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$148
- Impel Pharmaceuticals Inc.$77
- AbbVie$52
- Acorda Therapeutics, Inc$45
- Neurelis, Inc.$38
- Eisai Inc.$31
- plus $198 from 9 others
Across 2 payments — averaging $16,891 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novartis$34K
What the payments were for
- Food & beverage$588100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB, Inc. | 7 | $148 |
| Impel Pharmaceuticals Inc. | 3 | $77 |
| AbbVie | 2 | $52 |
| Acorda Therapeutics, Inc | 2 | $45 |
| Neurelis, Inc. | 2 | $38 |
| Eisai Inc. | 1 | $31 |
| SK Life Science, Inc. | 1 | $28 |
| Neurocrine Biosciences, Inc. | 1 | $27 |
| Tanabe Pharma America, Inc. | 1 | $26 |
| Bausch Health US, LLC | 1 | $25 |
| TG Therapeutics, Inc. | 1 | $24 |
| Acadia Pharmaceuticals Inc | 1 | $19 |
| Genentech USA, Inc. | 1 | $17 |
| Amgen | 1 | $17 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
How this compares
$588 in reported general payments places this provider in the 60th percentile of 469 physical medicine & rehabilitation providers in Michigan.
See all physical medicine & rehabilitation providers in Michigan →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pantoprazole Sodium | 11 | $82 |
Paid to pharmacies, not to this prescriber.
Other physical medicine & rehabilitation in Clinton Township
- Geoffrey SeidelClinton Township$3K
- Edward DabrowskiRoseville$167K
- Erika ErlandsonAnn Arbor$54K
- Gianna Maria RodriguezAnn Arbor$41K
- Mathew SaffarianEast Lansing$24K
- Jason PeterTroy$20K
- David WiersemaSaginaw$17K
- Satyum ParikhWarren$11K
- Reginald KapteynMuskegon$11K
- Emily GladstoneGrand Rapids$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.